ELCC 2017: Industry Participation

The European Lung Cancer Conference 2017 (ELCC 2017), is the most important conference in Europe for all clinical practitioners involved in the diagnostic work-up and treatment of lung cancer and other thoracic malignancies.

It brings together a unique community of medical professionals to facilitate the advancement of a personalised approach to the management of lung and other thoracic cancers and the implementation of new discoveries into clinical practice.

Fast facts: ELCC 2017

  • Expecting over 2200 international participants
  • Specialists and Key Opinion Leaders (KOLs) from all over the world in one place and as one community
  • 16 educational and 4 key note lectures sessions running over four days
  • An internationally renowned faculty
  • 9 Industry Satellite Symposia
  • Vibrant commercial exhibition
  • Excellent networking opportunities

Past attendance

ESMO gratefully acknowledges the valuable contribution of the following organisations in the ELCC Conferences over the years.

Past attendees
Abbott Laboratories Daiichi Sankyo Europe Olympus Medical Systems Europe
AbbVie Eli Lilly Otsuka Pharmaceuticals
Agennix Elsevier Pfizer Oncology
Amgen GE Healthcare Qiagen
Ariad Pharmaceuticals GSK Roche
Astrazeneca Helsinn Healthcare Rosetta Genomics
Bayer Schering Pharma Karl Storz Sanofi
Bristol-Myers Squibb Merck Serono Varian Medical Systems
Boehringer Ingelheim Microsulis Medical Ltd. Wisepress Ltd
Clovis Oncology MSD  
Cis Bio International Novartis Oncology  

How can I participate in ELCC 2017?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate their presence at our conferences.

Contact the ESMO Events Sponsorship Team for more details. We look forward to hearing from you!